Cargando…
Intensified and protective CD4(+) T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
Current human immunodeficiency virus (HIV) vaccine approaches emphasize prime boost strategies comprising multiple doses of DNA vaccine and recombinant viral vectors. We are developing a protein-based approach that directly harnesses principles for generating T cell immunity. Vaccine is delivered to...
Autores principales: | Trumpfheller, Christine, Finke, Jennifer S., López, Carolina B., Moran, Thomas M., Moltedo, Bruno, Soares, Helena, Huang, Yaoxing, Schlesinger, Sarah J., Park, Chae Gyu, Nussenzweig, Michel C., Granelli-Piperno, Angela, Steinman, Ralph M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118242/ https://www.ncbi.nlm.nih.gov/pubmed/16505141 http://dx.doi.org/10.1084/jem.20052005 |
Ejemplares similares
-
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
por: Tassaneetrithep, Boonrat, et al.
Publicado: (2003) -
In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers
por: Caskey, M, et al.
Publicado: (2012) -
Strategy for Identifying Dendritic Cell-Processed CD4(+) T Cell Epitopes from the HIV Gag p24 Protein
por: Bozzacco, Leonia, et al.
Publicado: (2012) -
APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection
por: Pion, Marjorie, et al.
Publicado: (2006) -
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
por: Choi, Jae-Hoon, et al.
Publicado: (2009)